CAR T Cells and T-Cell Therapies for Cancer
JAMA Clinical Reviews
00:00
Understanding Adverse Effects of CAR T-Cell Therapies
This chapter examines the side effects of CAR T-cell therapies, emphasizing cytokine release syndrome (CRS) and neurological toxicities linked to anti-CD19 treatments. It also addresses less common but serious effects associated with anti-BCMA CAR T cells, underscoring their importance in patient management after infusion.
Transcript
Play full episode
